Darolutamide Extends Survival in Metastatic Prostate Cancer - NCI
Por um escritor misterioso
Descrição
Adding darolutamide (Nubeqa) to ADT and docetaxel improves survival in hormone-sensitive metastatic prostate cancer, results from the ARASENS trial show.
Androgen receptor pathway inhibitors, prostate cancer, and older
Prostate cancer - InDepth - SmartEngage
Prostate Cancer Treatment (PDQ®) - PDQ Cancer Information
Phase 1 study of darolutamide (ODM-201): a new-generation androgen
Bayer expands global clinical program for darolutamide in prostate
A phase II study of docetaxel plus lycopene in metastatic castrate
Efficacy and safety outcomes of darolutamide in patients with non
FDA approves Bayer's Nubeqa® (darolutamide), a new treatment for
Current Oncology, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
